Delia Cangini - Concepedia

Author

Delia Cangini

University of Bologna

Also Known As

D Cangini, D. Cangini, Delia Cangini

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

University of Bologna Istituto Oncologico Romagnolo Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola Istituto di Ematologia di Bologna

About

Delia Cangini is an author at University of Bologna specializing in radiation oncology, oncology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	3	3	335
2	Medicine	3	3	335
3	Marrow Transplantation	2	2	189
4	Pharmacology	2	2	189
5	Cellular Therapies	1	1	179

Delia Cangini

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Prospective, Randomized Study of Single Compared With Double Autologous Stem-Cell Transplantation for Multiple Myeloma: Bologna 96 Clinical Study Michèle Cavo, Patrizia Tosi, Elena Zamagni, Journal of Clinical Oncology	2007	373
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma Michèle Cavo, Elena Zamagni, Patrizia Tosi, Blood	2005	365
A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma Elena Zamagni, Cristina Nanni, Francesca Patriarca, Haematologica	2007	350
First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma. Michèle Cavo, Elena Zamagni, Patrizia Tosi, Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) First-line TherapyCell TherapyPharmacotherapyMetronomic ChemotherapyImmunotherapy	2004	179
Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results Cristina Nanni, Elena Zamagni, Mohsen Farsad, European Journal of Nuclear Medicine and Molecular Imaging Bone Disease18F-fdg Pet/ctBone ImagingMedical ImagingBone Involvement	2006	146
Neuropathy in multiple myeloma treated with thalidomide R. Plasmati, Francesca Pastorelli, Michèle Cavo, Neurology	2007	126
Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation Simona Soverini, Michèle Cavo, Claudia Cellini, Blood	2003	120
Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure Patrizia Tosi, Elena Zamagni, Claudia Cellini, European Journal Of Haematology	2004	112
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma. Patrizia Tosi, Elena Zamagni, Claudia Cellini, PubMed	2002	111
Neurological toxicity of long‐term (>1 yr) thalidomide therapy in patients with multiple myeloma Patrizia Tosi, Elena Zamagni, Claudia Cellini, European Journal Of Haematology	2005	98

Page 1